EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Resmetirom: An Update on Therapy for Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Laurens A Van Kleef iD, Maurice Michel, Naim Alkhouri, Willem Pieter Brouwer iD, Jörn M Schattenberg iD

Drug Design, Development and Therapy · 2026

DOI: 10.2147/dddt.s559331 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Laurens A Van Kleef und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Fatty Liver, Non-alcoholic Fatty Liver Disease, Metabolic Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty LiverNon-alcoholic Fatty Liver DiseaseMetabolic DiseasesHumansSemaglutideAnimalsPyridazinesUracil

Stichwörter der Autor:innen

MASHMASLDfibrosispharmaceutical treatmentresmetirom

Substanzen

resmetiromSemaglutidePyridazinesUracil

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
  • Department of Internal Medicine II, University Medical Center Saarland, Homburg, Germany.
  • Medical Faculty, Saarland University, Saarbrücken, Germany.
  • Department of Hepatology, Arizona Liver Health, Chandler, AZ, USA.

ORCID-Profile: Laurens A Van Kleef, Willem Pieter Brouwer, Jörn M Schattenberg

Zitieren

APA

Van Kleef, L. A., Michel, M., Alkhouri, N., Brouwer, W. P., & Schattenberg, J. M. (2026). Resmetirom: An Update on Therapy for Metabolic Dysfunction-Associated Steatohepatitis (MASH). Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s559331

Vancouver

Van Kleef LA, Michel M, Alkhouri N, Brouwer WP, Schattenberg JM. Resmetirom: An Update on Therapy for Metabolic Dysfunction-Associated Steatohepatitis (MASH). Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s559331

BibTeX
@article{VanKleef2026,
  author = {Van Kleef, Laurens A and Michel, Maurice and Alkhouri, Naim and Brouwer, Willem Pieter and Schattenberg, Jörn M},
  title = {Resmetirom: An Update on Therapy for Metabolic Dysfunction-Associated Steatohepatitis (MASH)},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  doi = {10.2147/dddt.s559331}
}
Kostenlos starten →